Despite recommendations for universal vaccination of all individuals older than 6 months, influenza vaccine uptake in the United States remains dismal. Although there are clear benefits of large-scale vaccination in terms of both use of healthcare resources and improved work productivity, the issue of whether the influenza vaccine may prevent cardiovascular (CV) events has been controversial.
However, a new meta-analysis finds that the influenza vaccine may reduce the risk for CV events by more than one third among adults, and even more among adults at high risk for CV disease (CVD).[1] These findings could have important implications for public health policy, as well as the way in which physicians counsel individual patients regarding the use of the influenza vaccine.
No comments:
Post a Comment